|
Fun post
|
1
|
Resverlogix Corp.
|
May 22, 2015 12:25PM
|
|
For perspective
|
4
|
Resverlogix Corp.
|
May 19, 2022 02:22PM
|
|
Financing curiousity
|
3
|
Resverlogix Corp.
|
Jan 26, 2018 09:55AM
|
|
Financing
|
1
|
Resverlogix Corp.
|
Apr 26, 2024 11:18AM
|
|
FDA fast track
|
3
|
Resverlogix Corp.
|
Jul 09, 2015 01:12PM
|
|
FDA fast track
|
|
Resverlogix Corp.
|
Jul 09, 2015 01:12PM
|
|
F6 at IV
|
4
|
Resverlogix Corp.
|
Sep 18, 2017 01:11PM
|
|
Epigenetics in the Sept 8th Globe and Mail
|
4
|
Zenith Epigenetics
|
Sep 10, 2018 02:07PM
|
|
Epigenetics article in Nature
|
3
|
Resverlogix Corp.
|
Dec 07, 2015 08:27AM
|
|
Epigenetic Primer
|
5
|
Resverlogix Corp.
|
Jul 19, 2018 03:36PM
|
|
empagliflozin - a drug competitive to rvx-208???
|
|
Resverlogix Corp.
|
Nov 08, 2015 05:05PM
|
|
Easter
|
4
|
Resverlogix Corp.
|
Apr 01, 2021 04:32PM
|
|
Don's Milestones/ Major Achievements at RVX
|
5
|
Resverlogix Corp.
|
Sep 01, 2022 05:46PM
|
|
Don's discount
|
4
|
Resverlogix Corp.
|
Feb 04, 2018 04:07PM
|
|
Don must be happy
|
3
|
Zenith Epigenetics
|
Jun 15, 2022 12:39PM
|
|
Did I buy the wrong biotech ...
|
5
|
Resverlogix Corp.
|
May 09, 2023 09:35PM
|
|
Cytovance
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 11:34AM
|
|
Critique rvx-208 Science
|
4
|
Resverlogix Corp.
|
Nov 25, 2015 10:44AM
|
|
CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 10, 2016 10:19AM
|
|
Crazy Question
|
4
|
Resverlogix Corp.
|
Jan 05, 2024 09:37AM
|
